Question 1
2 out of 2 points
In which of these conditions would you expect an elevation of p53 expression in normal
cells?
Selected All of
Answer: these
Question 2
0 out of 2 points
Which of these TSGs plays an important role in the direct inactivation of a GTP-
bound Ras oncogene and when it is mutated can result in sporadic sarcomas in affected
patients?
Selected [None
Answer: Given]
Question 3
0 out of 2 points
In a patient with a constitutively active receptor tyrosine kinase that increases the
activity of PI3K, the administration of a drug that increases PTEN expression will likely
inhibit tumorigenesis because;
Selected PTEN competitively inhibits the catalytic
Answer: subunit of PI3K
Question 4
2 out of 2 points
You are evaluating a chemotherapeutic agent whose mode of action involves increasing
Cytochrome C release from the mitochondria of treated cells - this drug most likely
promotes the activity of this protein;
Selected BA
Answer: X
Question 5
0 out of 2 points
In a patient with Essential thrombocytemia, a mutation in JAK2 - a downstream effector
of cytokine receptor, results in a constitutive activation of the pseudokinase domain of
the receptor and an inhibition of signaling via this pathway.
Selected Tru
Answer: e
Question 6
2 out of 2 points
Which of these statements is not correct about Cytokine Receptor Signaling?
Selected They are the same as receptor tyrosine
Answer: kinases
Question 7
2 out of 2 points
Mutations in the human homologue of patched is responsible for hereditary nevoid basal
cell carcinoma
Selected Tru
This study source was downloaded by 100000830772748 from CourseHero.com on 01-23-2022 03:21:55 GMT -06:00
https://www.coursehero.com/file/62845991/BIOM-500-Quiz-1docx/